Saama Technologies has raised $40m from Perceptive Advisors to expand its AI-powered clinical data analytics platform, Life Science Analytics Cloud. The funding takes the firm’s total backing to $75m since 2015. In a statement, CEO and co-founder Dr. David Deamer said that “AI is changing medicine in ways we never imagined.” Its most recent developments include a virtual assistant, risk mitigation, drug efficacy and patient safety capabilities.
Saama Technologies has raised $40m from Perceptive Advisors to expand its AI-powered clinical data analytics platform, Life Science Analytics Cloud. The funding takes the firm’s total backing to $75m since 2015. CEO Suresh Katta said the deal would allow Saama to develop both the platform and applications. Its most recent developments include a virtual assistant, risk mitigation, drug efficacy and patient safety capabilities.